These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9044505

  • 1. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.
    Harris NL, Ferry JA, Swerdlow SH.
    Semin Diagn Pathol; 1997 Feb; 14(1):8-14. PubMed ID: 9044505
    [Abstract] [Full Text] [Related]

  • 2. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
    [Abstract] [Full Text] [Related]

  • 3. Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
    Kaleem Z, Hassan A, Pathan MH, White G.
    Arch Pathol Lab Med; 2004 Feb; 128(2):181-6. PubMed ID: 14736286
    [Abstract] [Full Text] [Related]

  • 4. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
    Gibson SE, Picarsic J, Swerdlow SH, Pantanowitz L.
    Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
    [Abstract] [Full Text] [Related]

  • 5. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.
    Collins MH, Montone KT, Leahey AM, Hodinka RL, Salhany KE, Belchis DA, Tomaszewski JE.
    Pediatrics; 2001 Jun; 107(6):E89. PubMed ID: 11389287
    [Abstract] [Full Text] [Related]

  • 6. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A, Amini RM, Hollander P, Molin D, Sundström C, Enblad G.
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [Abstract] [Full Text] [Related]

  • 7. [The spectrum of lymphoproliferations and malignant lymphoma after organ transplant].
    Müller-Hermelink HK, Ott G, Kneitz B, Rüdiger T.
    Verh Dtsch Ges Pathol; 2004 Jun; 88():63-8. PubMed ID: 16892535
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distinctive Clinicopathologic Features of Monomorphic B-cell Post-transplant Lymphoproliferative Disorders in Children.
    Zhang Y, Mariani R, Gong M, Kirschmann D, Caparelli E, Wallace N, Turner R, Lu X, Gao J, Yap KL, Gong S.
    Pediatr Dev Pathol; 2021 Jun; 24(4):318-326. PubMed ID: 33872109
    [Abstract] [Full Text] [Related]

  • 11. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.
    Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
    [Abstract] [Full Text] [Related]

  • 12. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach.
    Nalesnik MA.
    Transpl Infect Dis; 2001 Jun; 3(2):88-96. PubMed ID: 11395974
    [Abstract] [Full Text] [Related]

  • 13. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.
    Ramalingam P, Rybicki L, Smith MD, Abrahams NA, Tubbs RR, Pettay J, Farver CF, Hsi ED.
    Mod Pathol; 2002 Jun; 15(6):647-56. PubMed ID: 12065779
    [Abstract] [Full Text] [Related]

  • 14. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 15. Classification of the posttransplant lymphoproliferative disorders: from the past to the present.
    Swerdlow SH.
    Semin Diagn Pathol; 1997 Feb; 14(1):2-7. PubMed ID: 9044504
    [Abstract] [Full Text] [Related]

  • 16. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA.
    Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
    [Abstract] [Full Text] [Related]

  • 17. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR, Nalesnik MA, Swerdlow SH.
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [Abstract] [Full Text] [Related]

  • 18. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients.
    Wu TT, Swerdlow SH, Locker J, Bahler D, Randhawa P, Yunis EJ, Dickman PS, Nalesnik MA.
    Hum Pathol; 1996 Feb; 27(2):157-64. PubMed ID: 8617457
    [Abstract] [Full Text] [Related]

  • 19. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
    Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, Gandjbakhch I, Binet JL, Raphael M.
    J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203
    [Abstract] [Full Text] [Related]

  • 20. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.
    Chen W, Huang Q, Zuppan CW, Rowsell EH, Cao JD, Weiss LM, Wang J.
    Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.